JPH0430824B2 - - Google Patents
Info
- Publication number
- JPH0430824B2 JPH0430824B2 JP62245875A JP24587587A JPH0430824B2 JP H0430824 B2 JPH0430824 B2 JP H0430824B2 JP 62245875 A JP62245875 A JP 62245875A JP 24587587 A JP24587587 A JP 24587587A JP H0430824 B2 JPH0430824 B2 JP H0430824B2
- Authority
- JP
- Japan
- Prior art keywords
- food
- present
- dietary fiber
- gel
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 235000013305 food Nutrition 0.000 claims description 46
- 235000013325 dietary fiber Nutrition 0.000 claims description 20
- 102000004169 proteins and genes Human genes 0.000 claims description 18
- 108090000623 proteins and genes Proteins 0.000 claims description 18
- 235000018102 proteins Nutrition 0.000 claims description 10
- 235000021245 dietary protein Nutrition 0.000 claims description 8
- 239000000679 carrageenan Substances 0.000 claims description 6
- 235000010418 carrageenan Nutrition 0.000 claims description 6
- 229920001525 carrageenan Polymers 0.000 claims description 6
- 229940113118 carrageenan Drugs 0.000 claims description 6
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical group [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 6
- 230000002378 acidificating effect Effects 0.000 claims description 5
- 239000005018 casein Substances 0.000 claims description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 3
- 235000021240 caseins Nutrition 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000008280 blood Substances 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 18
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 11
- 230000000694 effects Effects 0.000 description 8
- 239000012530 fluid Substances 0.000 description 8
- 235000008429 bread Nutrition 0.000 description 7
- 206010012601 diabetes mellitus Diseases 0.000 description 7
- 102000004877 Insulin Human genes 0.000 description 6
- 108090001061 Insulin Proteins 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 230000002496 gastric effect Effects 0.000 description 6
- 229940125396 insulin Drugs 0.000 description 6
- 108010076119 Caseins Proteins 0.000 description 5
- 102000011632 Caseins Human genes 0.000 description 5
- 206010020710 Hyperphagia Diseases 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 235000020830 overeating Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000011194 food seasoning agent Nutrition 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 239000004278 EU approved seasoning Substances 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 230000000291 postprandial effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 229940080237 sodium caseinate Drugs 0.000 description 3
- 235000013599 spices Nutrition 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 235000016623 Fragaria vesca Nutrition 0.000 description 2
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 210000004211 gastric acid Anatomy 0.000 description 2
- 230000002641 glycemic effect Effects 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 244000307700 Fragaria vesca Species 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 208000002705 Glucose Intolerance Diseases 0.000 description 1
- 206010018429 Glucose tolerance impaired Diseases 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 108010033929 calcium caseinate Proteins 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 229940126904 hypoglycaemic agent Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000018984 mastication Effects 0.000 description 1
- 238000010077 mastication Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000012794 white bread Nutrition 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、ゲル状食品に関する。本発明のゲル
状食品は、糖尿病患者耐糖能の低下した患者にお
ける血糖値の急激な上昇を防止するための食品と
して使用される。さらに、本ゲル状食品は、過食
の防止用食品として使用される。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to gel-like foods. The gel-like food of the present invention is used as a food for preventing rapid increases in blood sugar levels in diabetic patients with decreased glucose tolerance. Furthermore, this gel-like food is used as a food for preventing overeating.
[従来の技術および問題点]
糖尿病などの耐糖能不全を伴う疾患の患者は、
通常の食事を通常の方法で摂取させると、血糖値
が急激に上昇し、高血糖症状を呈する。これは血
糖上昇抑制作用を有するインスリンの分泌不全や
インスリンの作用低下によるものであり、このよ
うな症状は糖尿病症状の悪化のみならずひいては
網膜症、腎障害、意識障害などの様々の合併症を
ひき起こす原因となる。[Conventional techniques and problems] Patients with diseases associated with glucose intolerance, such as diabetes,
When a normal meal is ingested in a normal manner, blood sugar levels rise rapidly, resulting in symptoms of hyperglycemia. This is due to insufficient secretion of insulin, which has the effect of suppressing blood sugar rise, and decreased insulin action, and these symptoms not only worsen diabetic symptoms but also lead to various complications such as retinopathy, kidney damage, and impaired consciousness. It may cause it.
従つて急激な血糖値の上昇を防止するために、
糖尿病患者などに対して、必要なカロリーを何回
にも分けて与えたり、血糖上昇作用の強い少糖類
の摂取制限を行なうなどの食事療法が採られてい
るが、患者やその家族にとつて煩雑である。 Therefore, in order to prevent a sudden rise in blood sugar levels,
Dietary therapy is used for diabetic patients and others, such as giving the necessary calories in multiple doses and restricting the intake of oligosaccharides, which have a strong effect on raising blood sugar, but this is not effective for patients and their families. It's complicated.
またインスリンや血糖降下剤の使用による薬物
療法もあるが、副作用があり望ましくない。 There is also drug therapy using insulin or hypoglycemic agents, but these are undesirable due to side effects.
さらに、食物繊維にも、食後血糖上昇抑制作用
があることが見出されているが、食物繊維を大量
に摂取しなければならなかつたり、投与方法が異
なると一定の効果が得られなかつたりで、未だ商
品化の段階まで研究が進んでいない。 Furthermore, dietary fiber has been found to have the effect of suppressing postprandial blood sugar rise, but it may not be possible to obtain a certain effect if a large amount of dietary fiber must be ingested or if the administration method is different. , research has not yet progressed to the commercialization stage.
[問題点を解決するための手段]
本発明の第1の目的は、糖尿病患者等の耐糖能
が低下した患者における急激な血糖値の上昇を防
止し得る食品を提供することにある。[Means for Solving the Problems] A first object of the present invention is to provide a food that can prevent rapid increases in blood sugar levels in patients with decreased glucose tolerance, such as diabetic patients.
本発明の第2の目的は、胃内滞留時間が長く、
栄養価の高いタンパク質を含有する肥満治療また
は予防に使用される過食防止用の提供することに
ある。 The second object of the present invention is to have a long gastric residence time.
An object of the present invention is to provide a product for preventing overeating that is used for obesity treatment or prevention and contains protein with high nutritional value.
かかる目的は下記の構成を有する本発明のゲル
状食品によつて達成される。 This object is achieved by the gel-like food product of the present invention having the following structure.
1 水溶性食物繊維と酸性領域に等電点を有する
タンパク質とを5W/V%以上含有し、前記水溶
性食物繊維とタンパク質の重量比が1:1〜1:
20であるゲル状食品。1 Contains 5W/V% or more of water-soluble dietary fiber and protein having an isoelectric point in an acidic region, and the weight ratio of the water-soluble dietary fiber and protein is 1:1 to 1:
Gel food that is 20.
2 水溶性食物繊維が、カラギナンである第1項
に記載の食品。2. The food according to item 1, wherein the water-soluble dietary fiber is carrageenan.
3 タンパク質が、カゼインまたはその塩である
第1項に記載の食品。3. The food according to item 1, wherein the protein is casein or a salt thereof.
4 水溶性食物繊維とタンパク質の重量比が1:
1〜1:20である第1項に記載の食品。4 The weight ratio of water-soluble dietary fiber and protein is 1:
1 to 1:20.
[発明の具体的説明]
本発明は上記のとおり水溶性食物繊維と酸性領
域に等電点を有するタンパク質とを5W/V%以
上含有するゲル状食品である。[Specific Description of the Invention] As described above, the present invention is a gel-like food containing water-soluble dietary fiber and a protein having an isoelectric point in an acidic region in an amount of 5 W/V% or more.
本発明において、水溶性食物繊維としては、カ
ラギナンまたはグアガムを用いることが望まし
く、カラギナンが特に望ましい。食物繊維は、糖
質や脂質の代謝を改善する作用を有することで近
年注目されている物質でもある。 In the present invention, it is desirable to use carrageenan or guar gum as the water-soluble dietary fiber, and carrageenan is particularly desirable. Dietary fiber is a substance that has received attention in recent years because of its ability to improve carbohydrate and lipid metabolism.
本発明において用いられるタンパク質は酸性領
域に等電点を有するものであつてカゼインまたは
その塩例えばカゼインナトリウムもしくはカゼイ
ンカルシウムが望ましい。 The protein used in the present invention has an isoelectric point in the acidic region, and is preferably casein or a salt thereof such as sodium caseinate or calcium caseinate.
本発明の食品は、上記食物繊維と上記タンパク
質との混合物を5W/V%以上の濃度となるよう
に熱湯に溶解したゲル状物である。上記食物繊維
とタンパク質の総計の濃度が5W/V%以下では、
ゲル化が不充分となり望ましくない。 The food of the present invention is a gel-like product prepared by dissolving a mixture of the above-mentioned dietary fiber and the above-mentioned protein in hot water to a concentration of 5 W/V% or more. If the total concentration of the above dietary fiber and protein is below 5W/V%,
This is undesirable because gelation becomes insufficient.
また水溶性食物繊維とタンパク質との割合は、
本発明の食品がゲル状となるような割合であり、
しかも本食品が胃液と接触した際に、ゲルが強化
されるような割合である。 In addition, the ratio of water-soluble dietary fiber to protein is
The ratio is such that the food of the present invention becomes gel-like,
Moreover, the ratio is such that when the food comes into contact with gastric fluid, the gel becomes stronger.
このような割合は水溶性食物繊維およびタンパ
ク質の種類とその組合せによつて異なるがおよそ
1:1〜1:20重量比である。 This ratio varies depending on the type and combination of water-soluble dietary fiber and protein, but is approximately 1:1 to 1:20 by weight.
水溶性食物繊維に対するタンパク質の量(重
量)が1倍より少ない場合は、本発明の食品が胃
液と接触してもゲル塊を形成せず、また20倍より
多くなるとタンパク質が水溶性食物繊維と分離し
沈澱するので、ゲル塊を形成しない。 When the amount (weight) of protein to water-soluble dietary fiber is less than 1 times, the food of the present invention does not form a gel mass even when it comes into contact with gastric juice, and when it is more than 20 times, protein becomes water-soluble dietary fiber. It separates and precipitates, so it does not form a gel mass.
本発明の食品は、胃中でさらにゲル塊を形成し
て、同時に摂取した食品中の糖質の消化吸収過程
への移行を遅延させる。これによつて糖尿病等の
患者の血糖値の急激な上昇を防ぐことができる。
また、ゲルは胃内に滞在する他の飲食物に含まれ
ていた糖質を吸収して、その体内への吸収を遅ら
せる。 The food of the present invention further forms a gel mass in the stomach, thereby delaying the transition of carbohydrates in the simultaneously ingested food to the digestive and absorption process. This can prevent rapid increases in blood sugar levels in patients with diabetes and the like.
The gel also absorbs carbohydrates from other foods and drinks that stay in the stomach, slowing their absorption into the body.
従つて、消化吸収が早く、食後血糖上昇作用の
強い(グリセミツクインデツクスの高い)食品、
例えばパン、ケーキ等に塗布して摂取すると効果
が大きい。本発明の食品は、咀嚼の過程でこれら
の食品と混合された後、胃内で胃酸と接触して全
体がゲル塊を形成し、同時に摂取した食品の胃内
滞留時間を長くして消化吸収過程への移行を遅延
させる。このことより、食後の血糖上昇を抑制す
ることが可能となる。また、胃内滞留時間が長く
なることにより、胃に対して機械的伸展刺激が長
時間にわたつて加わり、食欲を抑制することがで
き、ひいては過食の防止になる。 Therefore, foods that are quickly digested and absorbed and have a strong postprandial blood sugar raising effect (high glycemic index),
For example, it is highly effective when ingested by applying it to bread, cakes, etc. After the food of the present invention is mixed with these foods during the mastication process, it comes into contact with gastric acid in the stomach to form a gel mass, and at the same time prolongs the residence time of the ingested food in the stomach and improves digestion and absorption. Delay transition to process. This makes it possible to suppress postprandial blood sugar rise. Furthermore, by increasing the residence time in the stomach, mechanical stretching stimulation is applied to the stomach over a long period of time, and appetite can be suppressed, thereby preventing overeating.
本発明による食品は、呈味性が低いので、少量
の調味料、香辛料、フレーバー、甘味料などを添
加することによつて、容易に嗜好性を高めること
が可能である。これら調味料、香辛料、フレーバ
ーは通常用いられるもののうち1種類または2種
類以上を組合わせて用いることができる。 Since the food according to the present invention has a low taste, palatability can be easily increased by adding small amounts of seasonings, spices, flavors, sweeteners, etc. These seasonings, spices, and flavors can be used singly or in combination of two or more of the commonly used seasonings, spices, and flavors.
本発明による食品は、ジヤム様、ペースト様等
にすることができる。ジヤム様にする場合には、
ストロベリー、グレープフルーツ、オレンジ、レ
モン、ペパーミント、ブルーベリー等のフレーバ
ーと甘味料を用いる。甘味料は、アスパルテー
ム、サツカリン、還元麦芽糖などの低カロリーの
ものを用いることが望ましい。 The food product according to the invention can be made into jam-like, paste-like, etc. If you want to do it like Jiamu,
Use flavors and sweeteners such as strawberry, grapefruit, orange, lemon, peppermint, and blueberry. It is desirable to use a low-calorie sweetener such as aspartame, saccharin, or reduced maltose.
また、本発明の範囲を逸脱しない範囲で他の栄
養成分たとえば炭水化物、ビタミン類、無機質類
を加えてもよい。 Other nutritional ingredients such as carbohydrates, vitamins, and minerals may also be added without departing from the scope of the present invention.
以下実施例を示して本発明をさらに詳しく説明
する。 The present invention will be explained in more detail below with reference to Examples.
実施例 1
カラギナンVX‐16(三菱アセテート(株)製)1
gおよびカゼインナトリウム(和光純薬(株)製)4
gを80℃の熱湯100mlに溶解し本発明のゲル状食
品を得た。Example 1 Carrageenan VX-16 (manufactured by Mitsubishi Acetate Co., Ltd.) 1
g and sodium caseinate (manufactured by Wako Pure Chemical Industries, Ltd.) 4
g was dissolved in 100 ml of boiling water at 80°C to obtain a gel-like food of the present invention.
この食品に、ストロベリーエツセンス
(三栄
化学工業(株)製)0.1mlとパルスイート
1/60(味
の素(株)製)3gを加え、溶解後、室温に放置し冷
却した。この食品30gを市販の食パン1枚に塗布
し、被験者に口中で咀嚼を加えさせた後、その一
部を50mlのビーカーに吐き出させた。 To this food, 0.1 ml of Strawberry Essence (manufactured by Sanei Chemical Industry Co., Ltd.) and 3 g of Palsweet 1/60 (manufactured by Ajinomoto Co., Ltd.) were added, dissolved, and then allowed to cool at room temperature. 30 g of this food was applied to a piece of commercially available bread, and the subjects were asked to chew it in their mouths and then spit out a portion into a 50 ml beaker.
一方、同じ市販の食パンを同じ被験者に口中で
咀嚼を加えさせた後、その一部を別の50mlビーカ
ーに吐き出させて対照とした。 On the other hand, as a control, the same subjects chewed the same commercially available bread in their mouths and then spit out a portion into a separate 50ml beaker.
両ビーカーに40℃に加温した人工胃液(日本薬
局方、崩壊試験法第1液)を30mlずつ加え、性状
の変化を観察した。 30 ml of artificial gastric fluid (Japanese Pharmacopoeia, disintegration test method liquid 1) heated to 40°C was added to both beakers, and changes in properties were observed.
本発明の食品を塗布した食パンの咀嚼物は、人
工胃液との接触ですみやかに強固なゲル塊を形成
した。一方、対照群の食パンの咀嚼物は、容易に
人工胃液中に分散した。 The chewable bread coated with the food of the present invention quickly formed a firm gel mass upon contact with the artificial gastric fluid. On the other hand, the chewed bread of the control group was easily dispersed in the artificial gastric fluid.
さらに、人工胃液中で形成されたゲル塊を取り
出し、別の50mlビーカーに移した後、30mlの人工
腸液(日本薬局方崩壊試験法第2液)を加えたと
ころ、容易にゲルは崩壊し、人工腸液中に分散し
た。 Furthermore, when the gel mass formed in the artificial gastric fluid was taken out and transferred to another 50 ml beaker, 30 ml of artificial intestinal fluid (Japanese Pharmacopoeia disintegration test method liquid 2) was added, and the gel collapsed easily. Dispersed in artificial intestinal fluid.
実施例 2
カラギナンCS‐215(三栄化学工業(株)製)1.5g
およびカゼインナトリウム(和光純薬(株)製)3.5
gを80℃の熱湯100mlに溶解し本発明のゲル状食
品を得た。Example 2 Carrageenan CS-215 (manufactured by Sanei Chemical Industry Co., Ltd.) 1.5 g
and sodium caseinate (manufactured by Wako Pure Chemical Industries, Ltd.) 3.5
g was dissolved in 100 ml of boiling water at 80°C to obtain a gel-like food of the present invention.
この食品に、ビーフコンソメ調味料(富士食品
(株)製)5gを加えて溶解した後、室温に放置し冷
却した。この食品を、食パン1枚につき30g塗布
し3枚を健常者に約10分間で摂取させた。 Add beef consommé seasoning (Fuji Foods) to this food.
Co., Ltd.) and dissolved therein, the mixture was left to stand at room temperature and cooled. 30g of this food was applied to each slice of bread, and three slices were ingested by healthy subjects in about 10 minutes.
一方、対照として同じ被験者に対して、一週間
後に、食パン3枚を約10分間で摂取させた。 On the other hand, as a control, the same subjects were given three slices of white bread in about 10 minutes one week later.
摂取前0分、および摂取終了後、30分、60分、
90分、120分、180分の時点で上腕より採血し、血
糖および血中インスリン濃度を測定した。 0 minutes before intake, and 30 minutes, 60 minutes after completion of intake,
Blood was collected from the upper arm at 90, 120, and 180 minutes, and blood sugar and blood insulin levels were measured.
図に示すごとく、食パンに本発明の食品を塗布
することにより食後30分値における血糖値の上昇
が抑えられた。また、摂取後の全時点において血
中インスリン濃度は低値を示し、インスリンの節
約効果が認められた。 As shown in the figure, by applying the food of the present invention to bread, the increase in blood sugar level 30 minutes after a meal was suppressed. In addition, blood insulin levels were low at all time points after ingestion, indicating an insulin-saving effect.
[発明の効果]
以上詳述したように、本発明によるゲル状食品
は、水溶性の食物繊維と、酸性領域に等電点を有
するタンパク質とを5W/V%以上の濃度で含有
し、前記水溶性食物繊維とタンパク質の重量比が
1:1〜1:20であるものであり、これをグリセ
ミツクインデツクスの高い食品に塗布し摂取する
ことにより、口中で咀嚼混合され、胃内で胃酸と
接触し強固なゲル塊を形成するものである。[Effects of the Invention] As detailed above, the gel-like food according to the present invention contains water-soluble dietary fiber and a protein having an isoelectric point in an acidic region at a concentration of 5 W/V% or more. The weight ratio of water-soluble dietary fiber and protein is 1:1 to 1:20, and by applying this to food with a high glycemic index and ingesting it, it is chewed and mixed in the mouth, and gastric acid is absorbed in the stomach. It forms a strong gel mass when it comes into contact with.
通常摂取物の胃内滞留時間は、摂取物の粘度が
大きいほど長くなるので、本発明品を他の食品に
塗布して同時に摂取すれば、当該他の食品の胃内
滞留時間も遅延し、消化吸収過程への移行が遅れ
て、糖質の体内への吸収を遅延させ、それにより
急激な血糖値の上昇を防止することができる。こ
の点において、肥満症患者よ糖尿病患者のように
耐糖能が低下している患者において、食後の高血
糖の発症を有効に防止し得る。 Normally, the residence time of ingested food in the stomach increases as the viscosity of the ingested food increases, so if the product of the present invention is applied to other foods and ingested at the same time, the residence time of the other foods in the stomach will be delayed. The transition to the digestive and absorption process is delayed, which delays the absorption of carbohydrates into the body, thereby preventing a rapid rise in blood sugar levels. In this respect, the onset of postprandial hyperglycemia can be effectively prevented in patients with decreased glucose tolerance, such as obese patients and diabetic patients.
また、本発明の食品を食前に、または他の食品
と一緒に摂取すれば、他の食品は少量しか摂取し
なくても胃に対して機械的伸展刺激が長時間にわ
たつて加わり、食欲を抑制することができ、ひい
ては過食の防止になる。 In addition, if the food of the present invention is taken before meals or with other foods, mechanical stretching stimulation is applied to the stomach over a long period of time even if only a small amount of other foods are ingested, suppressing appetite. This can help reduce overeating and prevent overeating.
なお、胃中で形成された本発明の食品のゲル
は、腸液と接触した場合には容易に崩壊するた
め、腸における栄養成分の吸収は阻害されず、患
者が栄養不良状態におちいる危険性はない。 Furthermore, since the gel of the food of the present invention formed in the stomach easily disintegrates when it comes into contact with intestinal fluid, the absorption of nutritional components in the intestine is not inhibited, and there is no risk of the patient becoming malnourished. do not have.
図は、食後30分後毎の血糖値と血中インスリン
濃度を示すグラフである。
The figure is a graph showing the blood sugar level and blood insulin concentration every 30 minutes after a meal.
Claims (1)
タンパク質とを5W/V%以上含有し、前記水溶
性食物繊維とタンパク質の重量比が1:1〜1:
20であるゲル状食品。 2 水溶性食物繊維がカラギナンである特許請求
の範囲第1項に記載の食品。 3 タンパク質がカゼインまたはその塩である特
許請求の範囲第1項に記載の食品。[Claims] 1. Contains 5W/V% or more of water-soluble dietary fiber and protein having an isoelectric point in an acidic region, and the weight ratio of the water-soluble dietary fiber and protein is 1:1 to 1:1.
Gel food that is 20. 2. The food according to claim 1, wherein the water-soluble dietary fiber is carrageenan. 3. The food according to claim 1, wherein the protein is casein or a salt thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62245875A JPH0191759A (en) | 1987-10-01 | 1987-10-01 | Gelatinous food |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62245875A JPH0191759A (en) | 1987-10-01 | 1987-10-01 | Gelatinous food |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0191759A JPH0191759A (en) | 1989-04-11 |
JPH0430824B2 true JPH0430824B2 (en) | 1992-05-22 |
Family
ID=17140105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62245875A Granted JPH0191759A (en) | 1987-10-01 | 1987-10-01 | Gelatinous food |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0191759A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6229947A (en) * | 1985-07-31 | 1987-02-07 | Ajinomoto Co Inc | Production of gel containing hardly digestible polysaccharide |
-
1987
- 1987-10-01 JP JP62245875A patent/JPH0191759A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6229947A (en) * | 1985-07-31 | 1987-02-07 | Ajinomoto Co Inc | Production of gel containing hardly digestible polysaccharide |
Also Published As
Publication number | Publication date |
---|---|
JPH0191759A (en) | 1989-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6468962B1 (en) | Nutritional intervention composition for enhancing and extending satiety | |
US20220125093A1 (en) | Nutritional supplements including meal replacements and related methods | |
PT1588629E (en) | Matrix-forming composition containing pectin | |
JP2006503105A (en) | Nutritional composition rich in leucine | |
CA2379180C (en) | Methods for suppressing appetite and enhancing exercise and recovery | |
NO763970L (en) | ||
WO1988001477A1 (en) | Food composition | |
US6905702B1 (en) | Methods for regulating blood glucose and appetite suppression in type 2 diabetics | |
ZA200308672B (en) | Method and composition for prophylaxis of diabetes. | |
JPS60188403A (en) | Composition | |
JP2000189109A (en) | Liquid food | |
WO2001033976A1 (en) | Methods for regulating blood glucose and appetite suppression in type 2 diabetics | |
EP1712139A1 (en) | Sustained energy release compositions | |
JP3165743B2 (en) | Liquid food | |
Zillikens et al. | Effects of the glucosidase inhibitor acarbose in patients with liver cirrhosis | |
JPH0430824B2 (en) | ||
JPH0364098B2 (en) | ||
JP2001233783A (en) | Preoperative nutrient agent | |
EP1123013A1 (en) | Product and method for providing glutamine | |
WO1995017199A1 (en) | Novel therapeutic carbohydrate blends useful for aiding sleep disorders | |
Reif-Lehrer | Adverse Reactions in Humans thought to be Related to Ingestion of Elevated Levels of Free Monosodium Glutamate (MSG) Chinese Restaurant Syndrome and Other Reactions | |
Lagua | I. Chemical symbol for iodine. Iatrogenic. Tenn meaning" caused by medical treatment or diagnostic proce-dures." Iatrogenic malnutrition is an in-duced nutritional deficiency due to drug | |
JPWO2012029728A1 (en) | Hypoglycemic agent and health food containing rice albumin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |